Herpes virus microRNA expression and significance in serous ovarian cancer

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Serous ovarian cancer (SEOC) is a highly lethal gynecologic malignancy.
• MicroRNAs (miRNAs) are key regulators of gene expression, and viral miRNAs can influence host cell functions.
• The role of viral miRNAs in SEOC pathogenesis and prognosis is largely unexplored.

Purpose of the Study:

• To investigate the expression and clinical significance of viral miRNAs in SEOC.
• To determine the prognostic value of specific viral miRNAs (miR-BART7 and miR-H25) in SEOC.
• To explore the functional impact of viral miRNAs on chemotherapy resistance and patient survival.

Main Methods:

• Analysis of miRNA sequencing data from 487 SEOC patients (TCGA).
• Quantitative immunofluorescence validation of miR-H25 in 161 SEOC patients.
• In vitro studies using ovarian cancer cell lines with miR-H25 and miR-BART7 transfection.
• Gene expression analysis, cytotoxicity assays, and survival analysis (Cox, Kaplan-Meier).

Main Results:

• Viral miRNAs are significantly more expressed in SEOC tissues compared to normal tissues.
• Herpetic viral miRNAs, miR-BART7 (EBV) and miR-H25 (HSV-2), are significant predictors of SEOC outcome.
• miR-BART7 correlates with chemotherapy resistance and poorer survival, while miR-H25 is associated with improved long-term survival.
• miR-BART7 promotes cisplatin resistance; miR-H25 affects RNA processing and human miRNA expression.

Conclusions:

• This study is the first to link viral miRNA expression to ovarian cancer prognosis.
• Viral miRNAs, specifically miR-BART7 and miR-H25, are promising biomarkers for SEOC diagnosis and outcome prediction.
• Targeting viral miRNAs may offer novel therapeutic strategies to improve SEOC treatment outcomes.